Amgen (AMGN)
$176.01
0.12 (0.07%)
AMGN Stock Quote Delayed 15 Minutes
Previous Close
$176.01
Market Cap
116.47B
PE Ratio
55.88
EPS
3.15
Volume (Avg. Vol.)
2.08M
Day's Range
175.52 - 176.77
52-Week Range
166.30 - 210.19
Dividend & Yield
5.28 (3.00%)
AMGN Stock Predictions, Articles, and Amgen News
Ranking the Top 10 Stock Buybacks of Last Year
The top ten stock buybacks by S&P 500 companies in 2018 totaled $252 billion. Here are the best stocks to buy of the bunch.
5 Top Stock Trades for Thursday: CVS, TWLO, EL, AMGN
CVS, Twilio, Amgen and Estee Lauder all reported earnings. Alibaba stock is breaking out. Here are our top stock trades to watch now.
Amgen Earnings: AMGN Stock Dips Slightly Despite Q1 EPS, Sales Beat
Amgen reported its latest quarterly earnings results after hours today, bringing in a profit that topped expectations, yet AMGN stock fell.
3 Big Stock Charts for Thursday: Citrix Systems, Goldman Sachs Group and Amgen
The stock charts of AMGN, CTXS and GS stock are ready to start the last trading day of the week on a trade-worthy foot.
Why Amgen Stock Could Break Out to New Highs
Amgen shares have a reasonable valuation, 3% dividend yield and a strong-looking chart. Is it time to buy AMGN stock now?
Amgen Earnings: AMGN Stock Slips on Q4 Earnings Beat, Weak Q1 Guidance
Amgen earnings (AMGN) were better than what analysts were calling for after hours, but AMGN stock slid as the its guidance missed the mark.
3 Big Stock Charts for Wednesday: Delta Air Lines, Amgen and Mondelez International
The stock charts of AMGN, DAL and MDLZ are put under the spotlight on this week's hump-day. Here's what to watch.
6 Pharmaceutical Stocks to Buy After the Midterms
The upside case for pharmaceutical stocks is building. The midterm elections results mean its unlikely drug price regulation will happen soon.
Gilead Sciences Stock Is Back to Base — Go Long
Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.
Will This FDA Approval Affect Amgen Stock Significantly?
AMGN stock is still riding on a rocky road despite news of a new FDA approval. Here's what Amgen investors need to know.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
